Cholangiocarcinoma (CCA) includes a cluster of highly heterogeneous biliary malignant
tumours that can arise at any point of the biliary tree. Their incidence is increasing globally …

Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …

The incidence of cholangiocarcinoma (CCA) has been increasing over the past few years.
Although there are surgery, chemotherapy and other conventional treatment methods, the …

Liver cancers are the fourth leading cause of cancer-related mortality worldwide. In the past
decade, breakthroughs in the field of artificial intelligence (AI) have inspired development of …

Background and Aims Accurately diagnosing malignant biliary strictures (MBSs) as benign
or malignant remains challenging. It has been suggested that direct visualization and …

Background Treatment patterns for intrahepatic cholangiocarcinoma (ICC) and extrahepatic
cholangiocarcinoma (ECC) differ, but limited studies exist comparing them. This study …

Cholangiocarcinoma (CCA) is an aggressive malignancy arising from the biliary epithelium.
It may occur at any location along the biliary tree with the perihilar area being the most …

Simple Summary Early and non-invasive diagnosis of cholangiocarcinoma (CCA) is still
challenging, thus largely contributing to the increased mortality rates observed worldwide …

Hepatobiliary cancers, including hepatocellular carcinoma (HCC), cholangiocarcinoma
(CCA), and gallbladder carcinoma (GBC), are lethal cancers with limited therapeutic options …

Cholangiocarcinoma (CCA) is an intractable malignant tumour with a high degree of
malignancy that is asymptomatic in the early stages. Exosomes have been shown in …